- Online ISSN : In-Process
CC BY 4.0
Open Access
Double-Blind
Continuous
No APC till Dec 2026
The Precision Journal of Disease Biology (PJDB)
PJDB is a peer-reviewed, open-access journal dedicated to publishing high-quality research in economics, finance, banking, accounting, and related disciplines. The journal provides an international platform for researchers, academics, practitioners, and policymakers to share original research, empirical studies, and theoretical advancements that contribute to the understanding of economic and financial issues.
Open Access Policy
All articles published in the The Precision Journal of Disease Biology (PJDB) are Gold Open Access, ensuring immediate and unrestricted availability upon publication with no embargo period. All content is distributed under the Creative Commons Attribution 4.0 (CC BY 4.0) license, allowing free use, sharing, and reproduction with appropriate attribution. This supports broad dissemination and increased global visibility of research outputs.
Publication Model
The journal operates under a Continuous Publication Model, whereby accepted manuscripts are published online promptly after completion of the peer-review and editorial process. This model ensures faster dissemination of research findings and enhances scholarly communication.
Publication Charges
For manuscripts submitted on or before 31 December 2026, there will be no article processing charges (APCs). The journal also does not impose any additional costs, including submission fees, editorial handling charges, language editing fees, colour charges or membership fees. All accepted articles will be published fully Open Access without any financial burden on authors.
Target Audience
The journal serves an international audience of researchers, academics, postgraduate students, economists, finance professionals, bankers, accountants, investment analysts, industry experts, and policymakers engaged in economics, finance, banking, accounting, financial technology, public policy, and related disciplines.
Ethics & Peer Review Policy
PJDB strictly follows guidelines of the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE). Each submission undergoes a rigorous double blind peer-review process to ensure originality, academic quality and methodological integrity. The journal uses advanced AI and plagiarism detection tools and maintains a strict zero-tolerance policy toward unethical practices, including plagiarism, data fabrication and inappropriate authorship.
Editorial Decision Timeline
The journal strives to communicate a final editorial decision within 60 days of manuscript submission, ensuring a timely, transparent, and efficient review process.
Latest Articles
Article ID: PD2601205001
Identification of Bioactive Postbiotics Against Neonatal Meningitis Caused by Group B Streptococcus via Srr2-Targeted In silico Screening
Precision Journal of Disease Biology (PJDB)
PJDB further aims to encourage scientific collaborations among researchers, clinicians, healthcare professionals, and academicians to support research that improves the prevention, diagnosis, and treatment of human diseases.
The journal provides an international platform for research advancing the understanding of disease biology, promote translational research, and foster innovative strategies to improve human health.
Journal Contact Information
For any inquiries regarding journal submissions, peer review, or general support, please contact the editorial office at pjdb@pdpublishers.com.
Latest Articles
Identification of Bioactive Postbiotics Against Neonatal Meningitis Caused by Group B Streptococcus via Srr2-Targeted In silico Screening
Article ID: PD2601205001